| Q34457533 | A microRNA-1280/JAG2 network comprises a novel biological target in high-risk medulloblastoma |
| Q37365043 | ABC transporter activity linked to radiation resistance and molecular subtype in pediatric medulloblastoma |
| Q48011531 | Adolescents and young adults with brain tumors in the context of molecular advances in neuro-oncology |
| Q58568139 | Adult Medulloblastoma: Occurrence of a Rare Event |
| Q36100967 | Adult medulloblastoma: A rare case report and literature review |
| Q55461188 | Adult medulloblastoma: feasibility and effectiveness of utilising high-dose chemotherapy with autologous stem cell rescue in newly diagnosed patients. |
| Q48723263 | An adult multifocal medulloblastoma with diffuse acute postoperative cerebellar swelling: immunohistochemical and molecular genetics analysis. |
| Q35774418 | An animal model of MYC-driven medulloblastoma |
| Q37420196 | BET bromodomain protein inhibition is a therapeutic option for medulloblastoma. |
| Q55462417 | Biological and clinical heterogeneity of MYCN-amplified medulloblastoma. |
| Q36629427 | Biomarker-driven stratification of disease-risk in non-metastatic medulloblastoma: Results from the multi-center HIT-SIOP-PNET4 clinical trial |
| Q48641521 | Can miRNA-based real-time PCR be used to classify medulloblastomas? |
| Q48381540 | Canonical TGF-β pathway activity is a predictor of SHH-driven medulloblastoma survival and delineates putative precursors in cerebellar development |
| Q38539478 | Chromosomal heterogeneity and instability characterize pediatric medulloblastoma cell lines and affect neoplastic phenotype |
| Q51542148 | Clinicopathological characteristics, molecular subgrouping, and expression of miR-379/miR-656 cluster (C14MC) in adult medulloblastomas. |
| Q41573477 | Complete and sustained response of adult medulloblastoma to first-line sonic hedgehog inhibition with vismodegib |
| Q37627692 | Cytogenetic prognostication within medulloblastoma subgroups |
| Q34330397 | DNA copy number alterations in central primitive neuroectodermal tumors and tumors of the pineal region: an international individual patient data meta-analysis |
| Q35896018 | Deep sequencing identifies IDH1 R132S mutation in adult medulloblastoma. |
| Q34859989 | Deregulated proliferation and differentiation in brain tumors. |
| Q38624646 | Distinctive localization and MRI features correlate of molecular subgroups in adult medulloblastoma. |
| Q64078625 | Downregulation of miR-204 expression defines a highly aggressive subset of Group 3/Group 4 medulloblastomas |
| Q38194990 | Duration of the pre-diagnostic interval in medulloblastoma is subgroup dependent |
| Q91665138 | EANO-EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma |
| Q45982851 | Early and persisting response to vismodegib in a patient with bone metastasizing medulloblastoma. |
| Q28302285 | G-protein coupled receptor expression patterns delineate medulloblastoma subgroups |
| Q61446577 | Identification of CD24 as a marker of Patched1 deleted medulloblastoma-initiating neural progenitor cells |
| Q38629781 | Imaging Biomarkers for Adult Medulloblastomas: Genetic Entities May Be Identified by Their MR Imaging Radiophenotype. |
| Q37999071 | Insights revealed by high-throughput genomic arrays in nonglial primary brain tumors. |
| Q40682183 | Integrating Molecular Subclassification of Medulloblastomas into Routine Clinical Practice: A Simplified Approach |
| Q39459649 | Integrating RNA sequencing into neuro-oncology practice. |
| Q38671456 | Intertumoral Heterogeneity within Medulloblastoma Subgroups |
| Q38120467 | Intertumoral and intratumoral heterogeneity as a barrier for effective treatment of medulloblastoma. |
| Q46018019 | Long-term outcomes of adult medulloblastoma patients treated with radiotherapy. |
| Q35925281 | MB3W1 is an orthotopic xenograft model for anaplastic medulloblastoma displaying cancer stem cell- and Group 3-properties |
| Q90654612 | Magnetic resonance spectroscopy in posterior fossa tumours: the tumour spectroscopic signature may improve discrimination in adults among haemangioblastoma, ependymal tumours, medulloblastoma, and metastasis |
| Q38123365 | Management of recurrent medulloblastoma in adult patients: a systematic review and recommendations |
| Q91596369 | Medulloblastoma |
| Q30040534 | Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations |
| Q49938109 | Medulloblastoma in adults : A retrospective single institution analysis |
| Q42562593 | Medulloblastoma in adults: they're not just big kids |
| Q54954567 | Medulloblastoma in the Molecular Era. |
| Q36493799 | Medulloblastoma subgroup-specific outcomes in irradiated children: who are the true high-risk patients? |
| Q35099027 | Medulloblastoma subgroups remain stable across primary and metastatic compartments |
| Q50604253 | Medulloblastoma: selecting children for reduced treatment. |
| Q91826570 | Medulloblastomics revisited: biological and clinical insights from thousands of patients |
| Q37469904 | Medulloblastomics: the end of the beginning |
| Q53201641 | MicroRNA-182 promotes leptomeningeal spread of non-sonic hedgehog-medulloblastoma. |
| Q37573700 | Molecular Classification of Medulloblastoma |
| Q90270316 | Molecular Heterogeneity and Cellular Diversity: Implications for Precision Treatment in Medulloblastoma |
| Q64087873 | Molecular markers and potential therapeutic targets in non-WNT/non-SHH (group 3 and group 4) medulloblastomas |
| Q36344704 | Molecular markers in pediatric neuro-oncology |
| Q38125031 | Molecular neuro-oncology in clinical practice: a new horizon |
| Q92865416 | Molecular stratifications, biomarker candidates and new therapeutic options in current medulloblastoma treatment approaches |
| Q36977713 | Molecular subgroups of adult medulloblastoma: a long-term single-institution study |
| Q35101347 | Molecular subgroups of medulloblastoma |
| Q34167499 | Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas |
| Q24615271 | Molecular subgroups of medulloblastoma: the current consensus |
| Q47827397 | Multicenter pilot study of radio-chemotherapy as first-line treatment for adults with medulloblastoma (NOA-07). |
| Q34369671 | Neuroradiology and histopathology in two cases of adult medulloblastoma |
| Q88732919 | Novel-smoothened inhibitors for therapeutic targeting of naïve and drug-resistant hedgehog pathway-driven cancers |
| Q47944360 | Obstacles to Brain Tumor Therapy: Key ABC Transporters |
| Q36634407 | Outcomes of adult medulloblastoma treated with a multimodality approach: A tertiary cancer center experience |
| Q35944343 | PI-3K Inhibitors Preferentially Target CD15+ Cancer Stem Cell Population in SHH Driven Medulloblastoma |
| Q98191465 | Pattern of Relapse and Treatment Response in WNT-Activated Medulloblastoma |
| Q39159565 | Patterns of care in adult medulloblastoma: results of an international online survey |
| Q39382947 | Pleiotropic effects of miR-183~96~182 converge to regulate cell survival, proliferation and migration in medulloblastoma |
| Q38689850 | Posterior Fossa Intra-Axial Tumors in Adults |
| Q66680444 | Precision Revisited: Targeting Microcephaly Kinases in Brain Tumors |
| Q64275194 | Principles of tumorigenesis and emerging molecular drivers of SHH-activated medulloblastomas |
| Q58565636 | Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial |
| Q33764662 | Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohort |
| Q37637737 | Proton beam craniospinal irradiation reduces acute toxicity for adults with medulloblastoma |
| Q37636027 | Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis |
| Q34296928 | Recurrent carotico-cavernous fistula after internal carotid artery ligation: a case with embolization of the fistula via contralateral internal carotid artery approach |
| Q53737190 | Refining medulloblastoma subgroups. |
| Q88993176 | Rethinking medulloblastoma from a targeted therapeutics perspective |
| Q36901551 | Risk stratification of childhood medulloblastoma in the molecular era: the current consensus |
| Q36956174 | Signaling pathway and molecular subgroups of medulloblastoma |
| Q50744249 | Somatostatin receptor subtype 2 (sst₂) is a potential prognostic marker and a therapeutic target in medulloblastoma. |
| Q48651234 | Sonic hedgehog-associated medulloblastoma arising from the cochlear nuclei of the brainstem |
| Q36929844 | Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma |
| Q37316068 | TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma |
| Q38184819 | The 'omics' of adrenocortical tumours for personalized medicine. |
| Q35100720 | The G protein α subunit Gαs is a tumor suppressor in Sonic hedgehog-driven medulloblastoma |
| Q39662585 | The Neuroradiological Spectra of Adult and Pediatric Medulloblastoma Differ : Results from a Literature-based Meta-analysis |
| Q38321654 | The RNA-binding protein Musashi1 affects medulloblastoma growth via a network of cancer-related genes and is an indicator of poor prognosis |
| Q38126476 | The TP73 complex network: ready for clinical translation in cancer? |
| Q36490004 | The WIP1 oncogene promotes progression and invasion of aggressive medulloblastoma variants |
| Q38112071 | The adolescent and young adult with cancer: state of the art--brain tumor |
| Q38008153 | The clinical implications of medulloblastoma subgroups |
| Q96576668 | The clinical treatment and outcome of cerebellopontine angle medulloblastoma: a retrospective study of 15 cases |
| Q35946293 | The molecular classification of medulloblastoma: driving the next generation clinical trials |
| Q46155460 | The role of angiogenesis in Group 3 medulloblastoma pathogenesis and survival |
| Q42647486 | Update on molecular and genetic alterations in adult medulloblastoma |
| Q37391485 | Update on the integrated histopathological and genetic classification of medulloblastoma - a practical diagnostic guideline |
| Q38053857 | What underlies the diversity of brain tumors? |
| Q38673795 | p53 and Meduloblastoma |